Scientific Information for Biotechnology companies David Elek – Global Director Library Sales...

download Scientific Information for Biotechnology companies David Elek – Global Director Library Sales Skolkovo Foundation, Moscow – 16.5.14.

If you can't read please download the document

Transcript of Scientific Information for Biotechnology companies David Elek – Global Director Library Sales...

  • Slide 1
  • Scientific Information for Biotechnology companies David Elek Global Director Library Sales Skolkovo Foundation, Moscow 16.5.14
  • Slide 2
  • Springer A leading global scientific, technical and medical publisher, providing researchers in academia, scientific institutions and corporate R&D departments with quality content via innovative information products and services Some 2,200 English-language journals and more than 8,400 new book titles published in 2013 More than 7,000 employees worldwide
  • Slide 3
  • History of Springer Springer was founded in 1842 in Berlin. Today - worlds largest scientific publisher with over 2,200 journals and 160,000 books. Key areas medicine, biomedicine & life sciences, computer science,mathematics, chemistry, physics, earth sciences. Symbol of the company is the knight (horse).
  • Slide 4
  • 21% of all Nobel Prize winners are Springer authors. Most of the top 200 pharma companies are Springer subscribers. Many new biotech start-ups are joining as well. Springer a brand-name you can trust (Including 2013 awards in Medicine, Physics, Chemistry and Economics)
  • Slide 5
  • Springer for R&D rd.springer.comrd.springer.com Immediate Access to Quality STM Research Thousands of eBooks, Journals and eReference Works on one platform Customized collections for your Industry Designed for Corporate Researchers A reliable resource delivering results faster, more relevant and more efficient Business Models for Companies of all Size Flexible, customizable purchase models and pricing for maximum ROI Special conditions for new Start-ups
  • Slide 6
  • Content Coverage All of the content currently available from Springer Organized and easy accessible for corporate users and organizations Browse by industry or science area Google like search on each page 185,000+ eBooks - 2005 current - Book Archives (110,000+) 2,200+ Journals - 1997-current - Journal Archives 35,000 Protocols300+ Reference Works Over 8.4 million documents Publishing partnerships with more than 500 scientific societies Largest Open Access publisher with more than 420 OA journals, including BioMed Central, the pioneering OA publisher
  • Slide 7
  • Springer for R&D Content Solutions for: Automotive Aerospace and Aeronautics Biotechnology Chemical Manufacturing Consumer Packaged Goods Electronics Energy, Utilities & Environment Engineering Finance, Business & Banking Hospitals & HealthIT & SoftwareLaw Materials & Steel Oil, Gas & Geosciences PharmaTelecommunications
  • Slide 8
  • Key Benefits Critical, trusted content that companies need to compete and succeed Available when and where it is neededanytime, anyplace Mobile optimized Faster and more relevant results rd.springer.comrd.springer.com page access is less than 2 seconds Semantic search increases relevancy Flexible business models Sophisticated tools for measuring content usage and evaluating ROI
  • Slide 9
  • Industry Collection Business Models Custom Journal Collections eBook Collections 12 collections, by copyright year Pay per View Deposit Model Custom Query Model New Start-up model Flexible business models whatever your company size and budget
  • Slide 10
  • Springer for Biotech http://rd.springer.com/industry/biotech Immediate Access to Quality STM Research in biotechnology Thousands of eBooks, Journals and eReference Works on one platform Designed for Corporate Researchers A reliable resource delivering results faster, more relevant and more efficient Business Models for Companies of all Sizes Flexible, customizable purchase models and pricing for maximum ROI
  • Slide 11
  • Pharma and Biotechnology Collection Springers Pharma and Biotechnology Collection includes a range of authoritative eBooks and eJournals covering current topics across all major areas of the field including: biomedical engineering, cancer research, human genetics, human physiology & immunology, microbiology, molecular medicine, and virology as well as other areas of pharmaceutical sciences. Access to more than 260 journals 1997 to current More than 7,500 eBooks 2005 to current
  • Slide 12
  • Pharma and Biotech Journal Highlights Pharmaceutical Research Diabetologia Breast Cancer Research and Treatment Osteoporosis International Cancer Chemotherapy and Pharmacology European Journal of Clinical Pharmacology Analytical and Bioanalytical Chemistry Psychopharmacology Molecular and Cellular Biochemistry Annals of Biomechanical Engineering Cellular and Molecular Life Sciences Journal of Molecular Neuroscience Journal of Pharmacokinetics and Pharmacodynamics
  • Slide 13
  • Book and Book Series Highlights The Prokaryotes Antibody Engineering Therapeutic Antibodies Hepatology Principles and Practice Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics Vaccine Adjuvants Drug discovery and Evaluation Prodrugs Understanding Biology Using Peptides
  • Slide 14
  • Free Preview available for all content Export Citations Related content based on your search criteria using semantic data Key data of the content item Extensive data on the content item Share via social media Advanced search and Search Help Article TOC
  • Slide 15
  • Springer Protocols Introducing the world's most comprehensive collection of peer-reviewed life sciences protocols - SpringerProtocols. Available through SpringerLink and springerprotocols.com's IP-enabled Protocol gateway, libraries and corporations can offer their patrons online access to the most worthwhile protocols instantly from multiple locations, including library, office, home or wherever they are. Includes more than 25,000 protocols with an additional 2,000 added each year Are based on tried and tested resources, including Methods in Molecular Biology Perpetual rights available Grouped in 15 fully indexed and searchable subject specific Online Libraries Interconnected on SpringerLink to all Springer content (Online Journals and eReferences) Fully integrated in your library catalogue MARC 21 records available COUNTER usage statistics No DRM (Digital Rights Management) Includes video protocols
  • Slide 16
  • Springer Images Over 3 Million Images! Scientific research has become progressively more focused on raw data and visual forms of learning and communication. These visuals come in many different forms, ranging from charts and graphs to high-quality photos. SpringerImages spans science, technology and medicine in 18 subject collections with over 3 million photos, graphs, histograms, tables and more. Over 3 million scientific, technical and medical images online. Over 500.000 added each year! Rapidly growing collection as images are added as they are published. Based on trusted sources, such as SpringerLink or images.MD. Not only searches the caption of the images, but also sentences from the full text which refer to the image.
  • Slide 17
  • Adis R&D Insight Your Window on Drug Development and Innovation Worldwide Adis R&D Insight is a drug pipeline database that tracks and evaluates drugs worldwide through the entire development process, from discovery, through pre-clinical and clinical studies to launch. It delivers the industrys most comprehensive combination of market and scientific drug development and innovation data. The Value of Powerful Market and Competitive Analysis Monitor the progress of competitors R&D programs Evaluate the strengths and weaknesses of compounds Assess the commercial potential of upcoming products Access key scientific data to support licensing opportunities Review success/failure rates of companies or technologies
  • Slide 18
  • Adis Clinical Trials Insight The New Standard in Rapid Evaluation of Clinical Trial Evidence Adis Clinical Trials Insight is the only database to capture on-going trials from internet trial registries as well as trial results presented at medical conferences and published in scientific journals. This unique perspective of the past, present, and future clinical landscape provides you with complete information to assess competitor studies, identify treatment gaps, and make strategic decisions. The Value of Intelligence to Guide Strategic Decisions : Identify clinical trials impacting your business Evaluate key study messages emerging from clinical studies Discover trials reporting new and important clinical evidence Assess the progress of competitor studies Uncover clinical evidence presented at recent meetings Map out where clinical trials are being conducted
  • Slide 19
  • Reactions Pharmacovigilance Insight Drug Safety Surveillance on Demand Reactions Pharmacovigilance Insight is a comprehensive database allowing you fast and easy access to the adverse drug reaction case reports, drug safety studies and regulatory news impacting your market. The Value of Monitoring Drug Safety Track regulatory activity and emerging safety issues worldwide for all drugs in your market Identify evidence that is not currently available in competitor drug information that can help you claim a safety advantage in a world where efficacy is comparable Locate good candidates for licensing or generic manufacturing by evaluating the safety advantages or issues for drugs in a specific area or class
  • Slide 20
  • Heidelberg with Venus April 15 2007 Thank you